Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

FRA:AIL - Deutsche Boerse Ag - FR0000120073 - Common Stock - Currency: EUR

183.84  -1.26 (-0.68%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AIL. AIL was compared to 66 industry peers in the Chemicals industry. While AIL has a great profitability rating, there are some minor concerns on its financial health. AIL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year AIL was profitable.
In the past year AIL had a positive cash flow from operations.
AIL had positive earnings in each of the past 5 years.
In the past 5 years AIL always reported a positive cash flow from operatings.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

AIL has a better Return On Assets (6.37%) than 80.30% of its industry peers.
With an excellent Return On Equity value of 12.31%, AIL belongs to the best of the industry, outperforming 80.30% of the companies in the same industry.
The Return On Invested Capital of AIL (9.63%) is better than 86.36% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AIL is above the industry average of 6.30%.
The 3 year average ROIC (9.47%) for AIL is below the current ROIC(9.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROIC 9.63%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

The Profit Margin of AIL (12.22%) is better than 92.42% of its industry peers.
In the last couple of years the Profit Margin of AIL has grown nicely.
AIL has a better Operating Margin (19.93%) than 95.45% of its industry peers.
In the last couple of years the Operating Margin of AIL has grown nicely.
With an excellent Gross Margin value of 63.01%, AIL belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
AIL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AIL is still creating some value.
AIL has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AIL has more shares outstanding
AIL has a better debt/assets ratio than last year.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.98. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
AIL's Altman-Z score of 3.98 is amongst the best of the industry. AIL outperforms 80.30% of its industry peers.
AIL has a debt to FCF ratio of 4.43. This is a neutral value as AIL would need 4.43 years to pay back of all of its debts.
AIL's Debt to FCF ratio of 4.43 is fine compared to the rest of the industry. AIL outperforms 78.79% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that AIL is not too dependend on debt financing.
AIL's Debt to Equity ratio of 0.37 is fine compared to the rest of the industry. AIL outperforms 62.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Altman-Z 3.98
ROIC/WACC1.32
WACC7.29%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

AIL has a Current Ratio of 0.88. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
AIL has a worse Current ratio (0.88) than 86.36% of its industry peers.
AIL has a Quick Ratio of 0.88. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.65, AIL is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
AIL does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.65
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

AIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.88%, which is quite good.
AIL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.55% yearly.
AIL shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
The Revenue has been growing slightly by 4.30% on average over the past years.
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%

3.2 Future

Based on estimates for the next years, AIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.90% on average per year.
AIL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.10% yearly.
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y9.9%
Revenue Next Year3.69%
Revenue Next 2Y3.9%
Revenue Next 3Y4.39%
Revenue Next 5Y5.1%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.59, AIL can be considered very expensive at the moment.
AIL's Price/Earnings ratio is in line with the industry average.
AIL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.82.
A Price/Forward Earnings ratio of 26.02 indicates a quite expensive valuation of AIL.
AIL's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of AIL to the average of the S&P500 Index (21.76), we can say AIL is valued inline with the index average.
Industry RankSector Rank
PE 28.59
Fwd PE 26.02
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

AIL's Enterprise Value to EBITDA ratio is in line with the industry average.
AIL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 38.02
EV/EBITDA 14.75
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AIL does not grow enough to justify the current Price/Earnings ratio.
AIL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.89
PEG (5Y)2.48
EPS Next 2Y10.48%
EPS Next 3Y10.45%

4

5. Dividend

5.1 Amount

AIL has a Yearly Dividend Yield of 1.78%.
AIL's Dividend Yield is comparable with the industry average which is at 3.03.
AIL's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years5
Div Non Decr Years5
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AIL pays out 51.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of AIL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.97%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (5/23/2025, 7:00:00 PM)

183.84

-1.26 (-0.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-22 2025-04-22
Earnings (Next)07-24 2025-07-24
Inst Owners27.5%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap106.34B
Analysts80.63
Price Target198.29 (7.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP51.97%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.14%
PT rev (3m)3.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.13%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE 28.59
Fwd PE 26.02
P/S 3.93
P/FCF 38.02
P/OCF 16.82
P/B 3.96
P/tB 10.43
EV/EBITDA 14.75
EPS(TTM)6.43
EY3.5%
EPS(NY)7.07
Fwd EY3.84%
FCF(TTM)4.84
FCFY2.63%
OCF(TTM)10.93
OCFY5.95%
SpS46.78
BVpS46.44
TBVpS17.62
PEG (NY)2.89
PEG (5Y)2.48
Profitability
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROCE 12.72%
ROIC 9.63%
ROICexc 10.08%
ROICexgc 17.03%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.34%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Debt/EBITDA 1.25
Cap/Depr 140.72%
Cap/Sales 13.03%
Interest Coverage 20.46
Cash Conversion 80.06%
Profit Quality 84.6%
Current Ratio 0.88
Quick Ratio 0.65
Altman-Z 3.98
F-Score8
WACC7.29%
ROIC/WACC1.32
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y9.9%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%
Revenue Next Year3.69%
Revenue Next 2Y3.9%
Revenue Next 3Y4.39%
Revenue Next 5Y5.1%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year58.93%
EBIT Next 3Y22.7%
EBIT Next 5Y16.13%
FCF growth 1Y-2.53%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y0.95%
OCF growth 3Y4.31%
OCF growth 5Y6.05%